JP2023538761A5 - - Google Patents
Info
- Publication number
- JP2023538761A5 JP2023538761A5 JP2023513348A JP2023513348A JP2023538761A5 JP 2023538761 A5 JP2023538761 A5 JP 2023538761A5 JP 2023513348 A JP2023513348 A JP 2023513348A JP 2023513348 A JP2023513348 A JP 2023513348A JP 2023538761 A5 JP2023538761 A5 JP 2023538761A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- methyl
- compound represented
- thiapenta
- propa
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2013383.1 | 2020-08-26 | ||
| GBGB2013383.1A GB202013383D0 (en) | 2020-08-26 | 2020-08-26 | Process |
| PCT/EP2021/073378 WO2022043320A1 (en) | 2020-08-26 | 2021-08-24 | Process |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023538761A JP2023538761A (ja) | 2023-09-11 |
| JP2023538761A5 true JP2023538761A5 (cg-RX-API-DMAC10.html) | 2025-10-14 |
| JP7818578B2 JP7818578B2 (ja) | 2026-02-20 |
Family
ID=72660759
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023513348A Active JP7818578B2 (ja) | 2020-08-26 | 2021-08-24 | プロセス |
Country Status (13)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202105661D0 (en) * | 2021-04-21 | 2021-06-02 | Givaudan Sa | Organic compounds |
| EP4554572A2 (en) | 2022-07-11 | 2025-05-21 | Symrise AG | Mixtures and uses of (2e)-3-(1,3-benzodioxol-5-yl)-n-phenyl-n-(tetrahydro-3-furanyl)-2-propenamide |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA987383B (en) * | 1997-08-19 | 2000-02-17 | Lilly Co Eli | Treatment of congestive heart failure with growth hormone secretagogues. |
| WO2006091731A2 (en) * | 2005-02-24 | 2006-08-31 | Teva Pharmaceutical Industries Ltd. | Processes for the preparation of linezolid intermediate |
| WO2007123405A1 (en) * | 2006-04-25 | 2007-11-01 | Dishman Pharmaceuticals And Chemicals Ltd. | Ropivacaine hydrochloride anhydrate and the preparation thereof |
| CA2869908C (en) * | 2012-04-25 | 2018-02-20 | Theravance Biopharma R&D Ip, Llc | Hepatitis c virus inhibitors |
| TWI610916B (zh) | 2012-08-03 | 2018-01-11 | 廣東東陽光藥業有限公司 | 作爲丙型肝炎抑制劑的橋環化合物及其在藥物中的應用 |
| EP3049435A4 (en) * | 2013-09-27 | 2017-03-29 | Merck Sharp & Dohme Corp. | Factor xia inhibitors |
| EP3054944B1 (en) * | 2013-10-07 | 2019-12-04 | Merck Sharp & Dohme Corp. | Factor xia inhibitors |
| CN108129476A (zh) * | 2017-11-27 | 2018-06-08 | 华中农业大学 | 一种杂环内酰胺衍生物及其用于作物病原菌杀菌剂的用途 |
| IL292156B2 (en) * | 2019-10-17 | 2026-05-01 | Givaudan Sa | Modified azacils as TRMP8 modulators |
-
2020
- 2020-08-26 GB GBGB2013383.1A patent/GB202013383D0/en not_active Ceased
-
2021
- 2021-08-24 JP JP2023513348A patent/JP7818578B2/ja active Active
- 2021-08-24 MX MX2023002234A patent/MX2023002234A/es unknown
- 2021-08-24 BR BR112023002055A patent/BR112023002055A2/pt unknown
- 2021-08-24 US US18/021,620 patent/US20230312506A1/en active Pending
- 2021-08-24 WO PCT/EP2021/073378 patent/WO2022043320A1/en not_active Ceased
- 2021-08-24 PL PL21769101.3T patent/PL4204407T3/pl unknown
- 2021-08-24 CN CN202511947370.0A patent/CN121717789A/zh active Pending
- 2021-08-24 EP EP21769101.3A patent/EP4204407B1/en active Active
- 2021-08-24 CN CN202180052436.3A patent/CN116209659A/zh active Pending
- 2021-08-24 IL IL300613A patent/IL300613A/en unknown
- 2021-08-24 KR KR1020237009953A patent/KR20230058096A/ko active Pending
- 2021-08-24 ES ES21769101T patent/ES2985349T3/es active Active
-
2023
- 2023-03-13 CO CONC2023/0003013A patent/CO2023003013A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL192454C (nl) | N,N'- digesubstitueerde ureum-, thioureum-, guanidine- en diaminoetheenderivaten, werkwijze voor de bereiding daarvan en farmaceutische preparaten die deze derivaten bevatten. | |
| JP2008511601A5 (cg-RX-API-DMAC10.html) | ||
| RU2009132186A (ru) | Способ получения соединений 2-аминотиазола в качестве ингибиторов киназы | |
| RU2011129325A (ru) | Циклическое карбодиимидное соединение | |
| JP2007528883A5 (cg-RX-API-DMAC10.html) | ||
| RU2005133994A (ru) | Оксимные производные и их применение в качестве фармацевтически активных агентов | |
| RU2013107023A (ru) | Способ получения производных аминобензоилбензофурана | |
| WO2015160772A1 (en) | Tetrahydro-benzoimidazolyl modulators of tgr5 | |
| JP2024519815A5 (cg-RX-API-DMAC10.html) | ||
| PE20040606A1 (es) | 4-amino-1-(piridilmetil)piperidina sustituida y compuestos relacionados | |
| SU479295A3 (ru) | Способ получени -карбамилзамещенных -пиразолинов | |
| JP2004525183A5 (cg-RX-API-DMAC10.html) | ||
| RU2008119994A (ru) | Ингибиторы калиевых каналов | |
| RU2013129993A (ru) | Новое производное пуринилпиридиниламино-2,4-дифторфенилсульфонамида, его фармацевтически приемлемая соль, способ его получения и фармацевтическая композиция, обладающая ингибирующей активностью в отношении raf-киназы, содержащая данное соединение в качестве активного ингредиента | |
| WO2016142952A1 (en) | Process for preparation of vilazodone and its novel intermediates | |
| CZ295996B6 (cs) | Způsob přípravy oxadiazinových derivátů | |
| RU94036760A (ru) | Производные триазина, его получение и использование | |
| JP2006523626A5 (cg-RX-API-DMAC10.html) | ||
| JP2021514399A5 (cg-RX-API-DMAC10.html) | ||
| JP2023525601A5 (cg-RX-API-DMAC10.html) | ||
| CN1942459A (zh) | 浆果赤霉素ⅲ化合物的简易合成方法 | |
| JP2006522034A5 (cg-RX-API-DMAC10.html) | ||
| KR880001614A (ko) | 콜린 수용체의 효능약인 신규의 트리시클릭 유도체 및 그를 함유하는 약물 | |
| RU2001101165A (ru) | Замещенные пятичленные гетероциклические соединения, фунгицидные композиции, содержащие их, и способы их получения | |
| BR9911624A (pt) | Compostos heterocìclicos substituìdos de cinco membros, composições fungicidas contendo os mesmos e processos para a produção dos mesmos |